Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Targets for antimigraine therapy: inhibitors of neurogenic plasma protein extravasation

June 18, 1997

Update on SIBIA Neurosciences' SIB-1508Y

June 18, 1997

Neuroprotective effects of ZD-9379 in rat model

June 17, 1997

Specific neuronal nicotinic cholinergic channel modulators from Abbott

June 17, 1997

GABArho receptor antagonists described by University of California

June 17, 1997

Botulinum toxin type A evaluated in cerebral palsy

June 16, 1997

Friedreich's ataxia: possible cause and potential treatments

June 16, 1997

Boston Life Sciences receives notice of patent allowance for CNS growth factor

June 16, 1997

BMS-180048 vs. placebo for acute treatment of migraine

June 16, 1997

Melatonin evaluated in emergency physicians on the night shift

June 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...